Literature DB >> 28797484

Overview of Treatment Approaches for Fungal Infections.

Eva M Carmona1, Andrew H Limper2.   

Abstract

Invasive fungal diseases cause high morbidity and mortality in an immunocompromised host. Antifungals are the drugs of choice and can be divided into 4 main groups: polyenes, azoles, echinocandins, and pyrimidine analogues. Each class has its specific mechanism of action, spectrum of activity, and pharmacokinetic and side effects. It is important to understand the precise use of the established and new antifungal agents to successfully manage these complex infections in an already tenuous and frail host. This article discusses the main characteristics, clinical uses, and secondary effects of the main antifungals used in clinical practice.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amphotericin; Antifungal; Echinocandins; Flucytosine; Fungal infections; Invasive mycoses; Triazoles

Mesh:

Substances:

Year:  2017        PMID: 28797484     DOI: 10.1016/j.ccm.2017.04.003

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  7 in total

1.  Alkylated Piperazines and Piperazine-Azole Hybrids as Antifungal Agents.

Authors:  Nishad Thamban Chandrika; Sanjib K Shrestha; Huy X Ngo; Oleg V Tsodikov; Kaitlind C Howard; Sylvie Garneau-Tsodikova
Journal:  J Med Chem       Date:  2017-12-19       Impact factor: 7.446

2.  Therapeutic Potential of Green Synthesized Gold Nanoparticles Using Extract of Leptadenia hastata against Invasive Pulmonary Aspergillosis.

Authors:  Basem M Abdallah; Enas M Ali
Journal:  J Fungi (Basel)       Date:  2022-04-24

3.  Retrospective cohort study comparing the risk of severe hepatotoxicity in hospitalized patients treated with echinocandins for invasive candidiasis in the presence of confounding by indication.

Authors:  Francis Vekeman; Lisa Weiss; Jalal Aram; Raluca Ionescu-Ittu; Shahrzad Moosavi; Yongling Xiao; Wendy Y Cheng; Rachel H Bhak; Margaret Tawadrous; M Rita Capparella; Philippe Montravers; Mei Sheng Duh
Journal:  BMC Infect Dis       Date:  2018-08-29       Impact factor: 3.090

4.  Antifungal activity of two oxadiazole compounds for the paracoccidioidomycosis treatment.

Authors:  Franciele Abigail Vilugron Rodrigues-Vendramini; Daniella Renata Faria; Glaucia Sayuri Arita; Isis Regina Grenier Capoci; Karina Mayumi Sakita; Silvana Martins Caparroz-Assef; Tania Cristina Alexandrino Becker; Patrícia de Souza Bonfim-Mendonça; Maria Sueli Felipe; Terezinha Inez Estivalet Svidzinski; Bernard Maigret; Érika Seki Kioshima
Journal:  PLoS Negl Trop Dis       Date:  2019-06-04

5.  Effective Inhibition of Invasive Pulmonary Aspergillosis by Silver Nanoparticles Biosynthesized with Artemisia sieberi Leaf Extract.

Authors:  Enas M Ali; Basem M Abdallah
Journal:  Nanomaterials (Basel)       Date:  2021-12-25       Impact factor: 5.076

Review 6.  Repurposing Antifungals for Host-Directed Antiviral Therapy?

Authors:  Sebastian Schloer; Jonas Goretzko; Ursula Rescher
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-10

Review 7.  Therapies and Vaccines Based on Nanoparticles for the Treatment of Systemic Fungal Infections.

Authors:  Brenda Kischkel; Suélen A Rossi; Samuel R Santos; Joshua D Nosanchuk; Luiz R Travassos; Carlos P Taborda
Journal:  Front Cell Infect Microbiol       Date:  2020-09-03       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.